We have a direct presence in 12 European countries, as well as Australia and New Zealand. We also have a strong global network of partnerships in non-Norgine markets. We are a flexible and fully integrated pharmaceutical business, with manufacturing (Hengoed, Wales and Dreux, France), third party supply networks and significant product development capabilities, in addition to our sales and marketing infrastructure. This enables us to acquire, develop and commercialise specialist and innovative products that make a real difference to the lives of patients around the world.
A core strength lies in our high quality manufacturing facilities and highly skilled staff.
We have the capabilities to manage various manufacturing scenarios from low volume and high value to high volume and low value, and, we are able to integrate new and innovative products.